Supporting Healthy Moms and Babies Act

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. _____/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H H.R. 7973, Momnibus Act; H.R. 7830, WELLS Act; S. 2433, Neonatal Care Transparency Act; S. 3698/H.R. 7227, Mental Health and MAMA Act; H.R. 6468, Rural Residency Planning and Development Act of 2025; H.R.8159, Gynecologic Pain Management Study Act; H.R.8160, Premenstrual Dysphoric Disorder Awareness and Research Act; H.R.7733, Ensuring OB-GYN Care In Prisons Act; H.R.7148, Consolidated Appropriations Act of 2026; S. Res. 590, Maternal Health Awareness Day Resolution; H.R. ____, Prepregnancy Healthcare Awareness Act; H.R. 7841, Warrior Infertility Act; Toxic Substances Control Act (TSCA); maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); funding for providers of reproductive health care (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S.____, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); Maternity Care Target Areas proposed updates; Emergency Medical Treatment and Active Labor Act (EMTALA)

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. _____/S. _____, Advancing Safe Medications for Moms and Babies Act;;Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 6242/S. 3274, Healthy MOM Act; H.R. 6096, NEST Act; H.R. 3670, IHS Provider Expansion Act; S. 1380/H.R. 4681, Specialty Physicians Advancing Rural Care (SPARC) Act; H.R. _____/S. _____, Black Maternal Health Momnibus Act; H.R. 5536, HEADACHE Act; H.R. 3633, Prevent HPV Cancers Act; maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); funding for providers of reproductive health care (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S.____, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS);; biomarker testing for preeclampsia (general); reproductive coercion (general);Richardson Waiver (general);

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); Advancing Safe Medications for Moms and Babies Act; E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials Draft Guidance (FDA-2025-D-1797); ;Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 2858/H.R. 5469, SHINE for Autumn Act; S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 2439/H.R4731, Resident Physician Shortage Reduction Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; S. 942/H.R. 2028, REDI Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); Public Service Loan Forgiveness program (general); maternal mortality review committees (general); HIPAA (general); reductions in force at HHS (general); caps on indirect research costs at NIH (general); removal of CDC online guidance (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); funding for providers of reproductive health care (general); IUD insertion (general); health IT (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); H.R. 4977/S. 141, Connected MOM Act; S. 2408/H.R. 4648, Access to Fertility Treatment and Care Act; H.R. 4611/S.2377, EACH Act; S. 1599, Midwives for MOMS Act; S. 1562/H.R. 1197, PREEMIE Reauthorization Act; S. 1380/H.R.4681, SPARC Act; S.Res. 401/H.Res. 739, National Stillbirth Prevention and Awareness Day Resolution; H.R. 4331, Access to Claims Data Act; H.R. 4417, Mobile Cancer Screening Act; S.____, Maternal Health Pandemic Response Act; H.R.____, HIV Medication Access Act; United States Preventive Services Taskforce (general); remote blood pressure monitoring (general); pelvic floor therapy (general); Affordable Care Act contraceptive mandate (general); pain management during gynecologic procedures (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); federal HIV guidelines (general); HPV testing (general); ; premenstrual dysphoric disorder (general); Pregnancy Risk Assessment Monitoring System (PRAMS); S.2296, National Defense Authorization Act for Fiscal Year 2026; H.R.3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

HR 1317/S 575: I CAN Act (Improving Care and Access to Nurses) Pregnancy Risk Assessment Monitoring System S 958: Tech to Save Moms HR 3762: Supporting Healthy Moms and Babies Act Medicaid HR 3593/S 1874: Title VIII Nursing Workforce Reauthorization Act of 2025

Client expense: $28,299 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1384, H.R. 2779 Abortion Funding Awareness Act; S.1834, H.R.3762 Supporting Healthy Moms and Babies Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Abortion Funding; Contraception Issues; IVF Issues

Client expense: $490,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1 One Big Beautiful Bill Act; S.1756, H.R.3411 Conscience Protection Act; H.R.2557 IVF For Military Families Act; S.2035 Protect IVF Act; S.1882, H.R.3589 RESTORE Act; S.J.Res. 56, H.J.Res.98 Life Month; H.R.3287 Pregnancy.Gov Act; S.1384, H.R. 2779 Abortion Funding Awareness Act; H.R. 2706 Aid Accountability Act of 2025; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; S.1834, H.R.3762 Supporting Healthy Moms and Babies Act; H.R. 589, S. 223 FACE Act Repeal of 2025; H.R.2075, S.987 Protecting Life and Integrity in Research Act of 2025; H.R.21, S. 6 Born-Alive Abortion Survivors Protection Act; Shield Laws; H.R. 1104, S. 230 Unborn Child Support; Unborn Child Tax Credit; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; S.2150, H.R. 12 Womens Health Protection Act; H.R. 685 Support and Value Expectant Moms and Babies Act; Chemical abortion drugs; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; Supporting Pregnant and Parenting Women and Families Act; S.178, H.R.627 Ensuring Accurate and Complete Abortion Data Reporting Act of 2025; Abortion Funding; Contraception Issues; IVF Issues; H.R. 353, S.1382 Family First Act; National Defense Authorization Act; H.R.271 Defund Planned Parenthood Act; S. 203 Defund Planned Parenthood Act; Supreme Court Decisions; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S. 1631 Restoring Safeguards for Dangerous Abortion Drugs Act; S.242 Dignity for Aborted Children Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions

H.R. 1 One Big Beautiful Bill Act; S.1756, H.R.3411 Conscience Protection Act; S.1882, H.R.3589 RESTORE Act; H.R.3287 Pregnancy.Gov Act; H.R. 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act; HR 1909 Preventing Maternal Deaths Reauthorization Act of 2025; H.R.1418 Purchased and Referred Care Improvement Act of 2025; S.1834, H.R.3762 Supporting Healthy Moms and Babies Act; H.R. 589, S. 223 FACE Act Repeal of 2025; H.R.21, S. 6 Born-Alive Abortion Survivors Protection Act; Shield Laws; S.1630, H.R.3235 More Opportunity for Moms to Succeed Act; H.R.4131, S.2172 Respectful Treatment of Unborn Remains Act of 2025; S.2150, H.R. 12 Womens Health Protection Act; H.R. 685 Support and Value Expectant Moms and Babies Act; H.R. 7, S. 186 No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025; Emergency Medical Treatment and Active Labor Act; Dismemberment Abortion Ban Act; S.178, H.R.627 Ensuring Accurate and Complete Abortion Data Reporting Act of 2025; Contraception Issues; National Defense Authorization Act; H.R.679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes; S.242 Dignity for Aborted Children Act; Administration Personnel and Judicial Nominees; Presidential Administration Actions

Client expense: $490,000 · Firm income: Not reported

Support for reproductive rights in the following legislation and government actions: H.R. 12/S. 2150, Womens Health Protection Act of 2025 H.R. 4104/S. 2149 Health Equity and Access under the Law (HEAL) For Immigrant Families Act of 2025 H.R. 3762/S. 1834, Supporting Healthy Moms and Babies Act H.R. 3218, Reproductive Data Privacy and Protection Act H.Res.369/S.Res.198, A resolution expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a reduction in public notice and comment opportunities. H.R. 3480, Health Coverage for IVF Act of 2025 H.Res 445, May as Sex Ed for All Month: Equity and Access for All S. 2189, A bill to amend the Internal Revenue Code of 1986 to treat certain assisted reproduction expenses as medical expenses of the taxpayer. H.R. 999/S.422, Right to Contraception Act H.R. 211, Equal Access to Contraception for Veterans Act Opposing provisions impacting reproductive rights in the following legislation:  H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities" and Sec. 44202 "Funding Cost Sharing Reduction Payments." * Section 71113 bars Essential Community Providers whose Medicaid reimbursements exceeded $800,000 in FY23 from receiving federal funds if they are primarily engaged in providing family planning or related reproductive health services and provide abortion care beyond the exceptions in the Hyde Amendment. * Section 44202 eliminates subsidies for Affordable Care Act marketplace insurance plans that cover abortion. Section 44202 was not included in the final version of H.R. 1. Opposing all provisions in the following legislation or administrative actions:  H.R. 589/S.223, FACE Act Repeal Act 2025/Restoring the First Amendment and Right to Peaceful Civil Disobedience Act of 2025 H.R. 1526, No Rogue Rulings Act of 2025 (NORRA) Opposing the nominations of: Mike Waltz, US Ambassador to the United Nations, US Mission to the United Nations Thomas March Bell, Inspector General, Department of Health & Human Services Elliot Gaiser, Asst. Attorney General, Department of Justice's Office of Legal Counsel Dr. Brian Christine, Asst. Secretary for Health, Department of Health & Human Services Michael Stuart, General Counsel, Department of Health & Human Services

Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; Teaching Health Center Graduate Medication Education program (general); H.R. 1, One Big, Beautiful Bill Act; H.R. 1909, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); SHINE for Autumn Act; S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 2059, Keeping Obstetrics Local Act; S. 2035, Protect IVF Act; H.R.3890, Resident Physician Shortage Reduction Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 4150, Advancing Maternal Health Equity Under Medicaid Act; Uterine Fibroid Intervention and Gynecological Health Treatment Act; S. 2004, Maternal and Infant Syphilis Prevention Act; H.R.3514/ S. 1816, Improving Seniors Timely Access to Care Act;S.1866 / H.R.2381, SCREENS for Cancer Act; H.R. 4084, Access to Birth Control Act; S. 942/H.R. 2028, REDI Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); Public Service Loan Forgiveness program (general maternal mortality review committees (general); HIPAA (general); reductions in force at HHS (general); caps on indirect research costs at NIH (general); removal of CDC online guidance (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); funding for providers of reproductive health care (general); Richardson Waiver; IUD insertion (general); health IT (general); prepregnancy health (general); Affordable Care Act (general); H.R. 3701, Family Vaccine Protection Act; Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); H.R. 4104/S. 2149, HEAL for Immigrant Families Act.